Lantheus Holdings, Inc.

LNTH · Healthcare · Drug Manufacturers - Specialty & Generic · Valued as of 2026-11-03 · Statements 2025-12-31

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

What it is worth

EPV + Growth

2.40B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

4.08B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

2.86B USD

15 years of cash for shareholders and lenders, less what is owed

Average Intrinsic Value

3.11B USD

The plain average of EPV, Profit and FCFF

Against the price

Market Cap

6.51B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.48×

the ratio the screener ranks by

Margin of Safety

-109.4%

1 − Market Cap / Average Intrinsic Value

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

Earnings power value plus growth: 2.40B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)2.43B USD
−②Net Debt Today31.69M USD
+③Growth Value0 USD
=Value2.40B USD

EPV of the Operations (NOPAT over WACC)

2.43B USD

Net debt today

-31.69M USD

Growth Value

0 USD

Value

2.40B USD

①EPV (earnings power value)

2.43B USD

②Net Debt Today

31.69M USD

③Growth Value

0 USD

Market value

Market Cap6.51B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-171.9%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 4.08B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE3.02B USD
+②Equity at Year 15, Today1.06B USD
=Value4.08B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

3.02B USD

②Equity at Year 15, Today

1.06B USD

Market value

Market Cap6.51B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-59.7%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 2.86B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF2.25B USD
+②Invested Capital at Year 15, Today643.18M USD
−③Net Debt Today31.69M USD
=Value2.86B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

2.25B USD

②Invested Capital at Year 15, Today

643.18M USD

③Net Debt Today

31.69M USD

Market value

Market Cap6.51B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-127.7%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 9.79%
Cost of Equity =Risk-Free Rate 4.50%+Beta (default) 1.00×Market Risk Premium 6.00%= 10.50%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 80.31M USDPretax Income 314.11M USD= 25.57%

The tax the interest saves.

Interest Expense =EBIT 333.87M USD−Pretax Income 314.11M USD= 19.77M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 19.77M USDTotal Debt 625.58M USD×(1 − Tax Rate for WACC 25.57%)= 2.35%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 625.58M USDMarket Cap + Total Debt 6.51B USD + 625.58M USD= 8.76%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 91.24%×Cost of Equity 10.50%+Debt Weight 8.76%×Cost of Debt 2.35%= 9.79%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 2.42B USD − Total Liabilities 1.10B USD = Book Value Today 1.31B USD

Total Debt 625.58M USD − Cash and Short-Term Investments 593.89M USD = Net Debt Today 31.69M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-4.8%at most 5%passes65,265,000 / 68,524,000
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets6.5%at least -10.0%passes(390.53M USD − 233.79M USD) ÷ 2.42B USD
Price to bookMarket Cap ÷ Book Value Today4.96×at most 3×does not pass6.51B USD ÷ 1.31B USD
Operating marginOperating Income ÷ Revenue20.5%above 10.0%passes315.87M USD ÷ 1.54B USD
Revenue growthRevenue ÷ Revenue a Year Before − 10.5%above 10.0%does not pass1.54B USD / 1.54B USD
Net cash(Cash − Total Debt) ÷ Market Cap-0.5%above -30%passes(593.89M USD − 625.58M USD) ÷ 6.51B USD
Operating efficiencyOperating Income ÷ Gross Profit33.5%above 25.0%passes315.87M USD ÷ 942.89M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

99.75 USD

Enterprise value

6.54B USD

the provider's own figure

EV / EBITDA

16.66×

Price / book

4.96×

the provider's book

Price / earnings

23.84×

Return on equity

22.2%

the provider's figure, not this page's

Profit margin

17.7%

Revenue growth

2.7%

Analyst target, mean

107.85 USD

Analysts

8

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

936.00M1.30B1.54B1.54B

Gross profit

582.28M710.25M989.28M942.89M

Operating income

36.23M365.01M449.01M315.87M

EBITDA

operating income before depreciation and amortisation

81.91M491.50M515.79M404.04M

Pretax income

26.75M411.35M431.41M314.11M

Net income

28.10M326.99M312.75M233.79M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

31.97M289.72M338.72M237.78M

R&D

311.99M77.78M168.27M177.49M
Balance sheet, year end

Total assets

1.32B1.65B1.98B2.23B

Total liabilities

874.99M836.09M893.22M1.14B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

447.59M816.71M1.09B1.09B

Total debt

584.09M617.56M620.06M620.05M

Cash and equivalents

416.07M714.37M913.73M359.48M

Net PP&E

fixed assets after depreciation

141.34M192.21M213.09M194.86M

Working capital

current assets less current liabilities

430.34M899.37M1.09B567.11M
Cash flow

Operating cash flow

282.06M305.57M545.29M390.53M

Capital expenditure

paid out, so below zero

-18.37M-46.60M-79.70M-41.54M

Depreciation and amortisation

47.98M60.10M64.69M70.17M

Free cash flow

operating cash flow plus capital expenditure

263.70M258.96M465.59M348.99M